KIMBERLEY ZINKOVICH: Open Payments
NPI 1568865731 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 66 payments from 28 companies in 2025. Trend: 2023 $1,344 · 2024 $2,012 · 2025 $1,433
Food & beverage: $1,338Education: $95
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $239 |
| GlaxoSmithKline, LLC. | 4 | $164 |
| Eisai Inc. | 4 | $163 |
| Gilead Sciences, Inc. | 5 | $158 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 4 | $71 |
| Merck Sharp & Dohme LLC | 4 | $66 |
| Celgene Corporation | 3 | $44 |
| SERVIER PHARMACEUTICALS LLC | 2 | $39 |
| Adaptive Biotechnologies Corporation | 2 | $35 |
Products named: ELREXFIO, Lenvima, Trodelvy, ZEJULA, KEYTRUDA, Enhertu, CARVYKTI, REBLOZYL.
Industry payments across IN — which companies pay providers there.
